Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
DeciBio News
DeciBio Forecasts the Rise of Allogeneic Therapies to Fuel the Worldwide Cell Therapy R&D and Manufacturing Market, Growing at 21% p.a. to Reach $14.5B by 2028 - Market Report by DeciBio Consulting LLC
DeciBio released a Cell Therapy R&D and Manufacturing market report that predicts the market will grow at 21% p.a. to reach $14.5B by 2028.
September 26, 2023
DeciBio News
DeciBio Forecasts the Rise of Allogeneic Therapies to Fuel the Worldwide Cell Therapy R&D and Manufacturing Market, Growing at 21% p.a. to Reach $14.5B by 2028 - Market Report by DeciBio Consulting LLC
DeciBio released a Cell Therapy R&D and Manufacturing market report that predicts the market will grow at 21% p.a. to reach $14.5B by 2028.
September 26, 2023
Cell & Gene Tx
In The Press
The Top 50 Healthcare Consultants and Leaders of 2023
Read our latest feature in The Top 50 Healthcare Consultants and Leaders of 2023.
September 20, 2023
In The Press
The Top 50 Healthcare Consultants and Leaders of 2023
Read our latest feature in The Top 50 Healthcare Consultants and Leaders of 2023.
September 20, 2023
DeciBio News
Infographic
Clinical Diagnostics
DeciBio NGS Clinical Oncology DxBook - Reimbursement
Following our exploration of competitive regional preferences for NGS tools, we've delved deeper into the pivotal role of reimbursements.
September 11, 2023
Infographic
Clinical Diagnostics
DeciBio NGS Clinical Oncology DxBook - Reimbursement
Following our exploration of competitive regional preferences for NGS tools, we've delved deeper into the pivotal role of reimbursements.
September 11, 2023
DeciBio News
DxBooks Data Insights
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | August Roundup 2023
Liquid Biopsy (LBx) continued to develop through August, with significant activity in early detection applications of LBx, as well as expanding medicare coverage of organ transplant rejection monitoring.
September 7, 2023
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | August Roundup 2023
Liquid Biopsy (LBx) continued to develop through August, with significant activity in early detection applications of LBx, as well as expanding medicare coverage of organ transplant rejection monitoring.
September 7, 2023
Liquid Biopsy
Infographic
Clinical Diagnostics
DeciBio NGS Oncology DxBook - Illumina vs. ThermoFisher
Our NGS Oncology DxBook reveals many interesting trends in clinical oncology NGS.
September 4, 2023
Infographic
Clinical Diagnostics
DeciBio NGS Oncology DxBook - Illumina vs. ThermoFisher
Our NGS Oncology DxBook reveals many interesting trends in clinical oncology NGS.
September 4, 2023
DeciBio News
DxBooks Data Insights
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved